Trillium Therapeutics
Financial ratios & Valuation

Historical Multiples (2012 – 2020)

2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.05-4.17-3.95-10.89-2.51-2.48-1.04-0.62-20.7529.70-6.70
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A209.858.32K44.96KN/A
Price/Book Value ratio
0.040.522.091.871.371.421.06-154.894.417.951.62
Price/Cash Flow ratio
-0.04-7.22-6.84-8.77-3.49-4.14-1.12-1.04-54.19-40.50-3.81
Price/Free Cash Flow ratio
-0.04-7.12-6.69-8.43-3.09-4.07-1.12-1.03-54.19-40.23-3.58
Price/Earnings Growth ratio
0.00-0.050.350.27-0.02-0.110.020.020.360.510.12
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A100%0.1%76.74%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A-28579.03%-41523.64%-161183.72%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A-33543.54%-40029.72%151911.62%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A-33566.12%-40098.64%151351.16%N/A
Effective Tax Rate
N/AN/A-2.80%-0.06%10.39%-0.00%-0.01%-0.06%-0.17%0.36%5.38%
Return on Assets
-67.70%-12.22%-45.70%-16.36%-47.63%-47.76%-76.60%-163.82%-19.72%24.52%-31.99%
Return On Equity
-76.78%-12.64%-53.00%-17.17%-54.59%-57.38%-102.12%24775%-21.28%24.68%-35.88%
Return on Capital Employed
-78.83%-12.51%-53.42%-24.55%-55.54%-51.32%-111.65%-298.29%-21.99%-28.46%-40.05%
Liquidity Ratios
Current Ratio
N/A45.737.7924.988.685.743.561.7213.9312.0316.83
Quick Ratio
8.2945.607.7925.008.685.743.551.7213.9311.5316.84
Cash ratio
7.4244.307.4124.398.531.951.551.0711.564.266.39
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A962.542.33K12.79KN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/A2.33KN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A19.48KN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/A-17.14KN/AN/A
Debt Ratios
Debt Ratio
0.110.030.010.000.000.00N/AN/A0.000.080.00
Debt Equity Ratio
0.130.030.010.000.000.00N/AN/A0.000.090.00
Long-term Debt to Capitalization
N/A0.000.010.000.000.00N/AN/AN/A0.000.00
Total Debt to Capitalization
N/A0.000.010.000.000.00N/AN/A0.000.000.00
Interest Coverage Ratio
N/A-107.11-219.18-401.50-693.36-758.12-1.15K-200.21N/AN/A-547.43
Cash Flow to Debt Ratio
N/A-7.26-26.28-67.67-119.90-275.89N/AN/A-82.96-72.99-96.45
Company Equity Multiplier
1.131.031.151.041.141.201.33-151.231.071.091.17
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A-200.87-153.60-1.11KN/A
Free Cash Flow / Operating Cash Flow Ratio
11.011.021.041.121.011.001.0111.001.07
Cash Flow Coverage Ratio
N/A-7.26-26.28-67.67-119.90-275.89N/AN/A-82.96-72.99-96.45
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-82.96-153.50N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A